Bone tissue engineering using bone marrow stromal cells and an injectable sodium alginate/gelatin scaffold

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Bone tissue engineering (BTE) seeks to repair or replace bone defects.
• Bone marrow stromal cells (BMSCs) are a potential cell source for BTE.
• Injectable scaffolds offer minimally invasive delivery for BTE applications.

Purpose of the Study:

• To evaluate the efficacy of BMSCs and an injectable sodium alginate/gelatin scaffold for BTE.
• To assess the osteogenic potential of BMSCs and the biocompatibility of the scaffold.
• To investigate the bone regeneration capacity of the scaffold-cell construct in vivo.

Main Methods:

• Osteogenic differentiation of BMSCs was confirmed via mineralized nodule formation and collagen type I expression.
• Cell proliferation was assessed using MTT assays.
• Scaffold-cell biocompatibility was evaluated using H&E staining.
• Bone formation and defect healing were analyzed in a rabbit calvarial critical-sized defect model using histology and CT scanning.

Main Results:

• High-purity osteogenic BMSCs were successfully derived.
• The sodium alginate/gelatin (2:3) scaffold demonstrated good biocompatibility with osteogenic cells after CaCl(2) cross-linking.
• The scaffold-cell construct promoted ectopic bone formation.
• Significant bone healing was observed in rabbit calvarial defects post-implantation.

Conclusions:

• The sodium alginate/gelatin scaffold is a suitable biomaterial for bone engineering.
• The combination of the scaffold with osteogenic BMSCs presents a promising approach for enhancing bone healing.
• This strategy offers a viable alternative for treating bone defects.